Biosensors International

IPO

HomePage | Biosensors International Ltd

Public · Singapore, Singapore · Founded 1990 · $200.0M raised

Headquarters
Singapore
Founded
1990
Business Model
B2B
Total Funding
$200.0M
Last Round
$200.0M Private EquityJan 2015
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Biosensors International Group is a Singapore-headquartered medical device company that has spent more than 25 years designing, manufacturing, and marketing innovative devices used in interventional cardiology and critical care, including its proprietary Biolimus A9 drug-eluting stent technology. The company operates worldwide with a European headquarters in Morges, Switzerland, and has grown into one of the largest global manufacturers and suppliers of cardiovascular stents, serving hospitals and cardiology specialists through direct sales and distributor networks.

Summary

Biosensors International is a Biotech company based in Singapore, Singapore, founded in 1990. It has raised $200.0M in total across 1 round, most recently a $200.0M Private Equity round in Jan 2015. Investors include Hony Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Private EquityPrivate Equity2015 (est.)
$200.0M

Sign up to see all 2 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Biosensors International on Indexed.vc
<a href="https://indexed.vc/companies/biosensors-international"><img src="https://indexed.vc/api/badge/company/biosensors-international" alt="Biosensors International on Indexed.vc" width="260" height="76" /></a>